HOW-TO7 min read·2026-01-29

How to Interpret Your IGF-1 Results on a GH Peptide Protocol

Understand what IGF-1 measures, optimal ranges by age, timing considerations, and how to adjust your protocol based on results.

# How to Interpret Your IGF-1 Results on a GH Peptide Protocol IGF-1 (Insulin-like Growth Factor 1) is the primary marker for growth hormone (GH) activity in your body. When you're running GH-releasing peptides, IGF-1 becomes your main feedback mechanism for assessing protocol efficacy.

What IGF-1 Measures

IGF-1 is a hormone produced primarily by the liver in response to growth hormone signaling. GH itself is pulsatile—it spikes and drops throughout the day—making it impractical to measure. IGF-1 is stable and integrates your overall GH production, giving a clear picture of your GH status over days and weeks.

Think of IGF-1 as a "GH output meter"—higher IGF-1 means your body produced more GH over the preceding 2-4 weeks.

Age-Based Optimal Ranges

IGF-1 naturally declines with age. Optimal ranges are age-dependent:

•**20-29 years**: 120-180 ng/mL (upper end of normal)

•**30-39 years**: 100-170 ng/mL

•**40-49 years**: 80-160 ng/mL

•**50-59 years**: 60-140 ng/mL

•**60+ years**: 50-120 ng/mL

Lab reference ranges often show a broader "normal" (80-240 ng/mL for adults), but for someone running GH-releasing peptides, aiming for the upper 40-60% of your age-appropriate range is typical. This represents enhanced GH signaling without excessive levels.

When to Draw and How Timing Affects Results

Timing relative to GH peptide injections matters significantly:

•**Best timing**: 8-12 hours post-injection (morning draw if you injected evening)

•**Avoid**: Drawing within 4 hours of injection (falsely elevated if measuring GH directly, though less relevant for IGF-1)

•**Consistency is critical**: Test at the same time of day, same day of the week, for 4-8 weeks post-protocol start

GH peptides take 2-4 weeks to elevate IGF-1 noticeably. Your first draw at week 2 may show minimal change; week 6-8 is when meaningful elevation appears. If you're testing too early or after only 1-2 weeks of protocol, don't expect dramatic changes.

Interpreting Your Results: The Decision Tree

Result: Within age-appropriate normal range (60-80th percentile)

•Your protocol is working. GH secretion is enhanced.

•Dose is appropriate; continue current protocol.

•Retest in 8-12 weeks to ensure stability.

Result: Below age-appropriate range (below 50th percentile)

•Either the peptide isn't working for you, the dose is too low, or protocol duration is too short.

•If you've been consistent for 6+ weeks: consider increasing dose by 0.5-1 IU (GHRP-6) or proportionally for other peptides.

•Rule out secondary issues: poor injection technique, batch quality, storage temperature, inconsistent timing.

•Retest 4 weeks after dose adjustment.

Result: Well above age-appropriate range (90th+ percentile)

•GH production is high. Side effects may emerge (joint pain, carpal tunnel, elevated glucose).

•Dose is likely too high for your current protocol.

•Consider reducing dose by 0.5 IU or decreasing injection frequency.

•Monitor for signs of acromegaly (hand/foot growth, jaw enlargement, excessive sweating)—rare but important at elevated levels.

•Retest 4 weeks after adjustment.

Result: Extreme elevation (>350 ng/mL in adults under 50)

•Potential over-suppression of somatostatin (inhibitor of GH), or non-compliance (accidentally overdosing).

•Stop or significantly reduce peptide dose.

•Test again in 2-4 weeks to confirm decline.

•Consult with your healthcare provider before resuming protocol.

The Dose-Response Relationship

IGF-1 generally shows a dose-response curve: more GH peptide (up to a point) produces higher IGF-1. However, this isn't perfectly linear:

•1 IU GHRP-6 daily might raise IGF-1 by 20 ng/mL

•2 IU might raise it by 35 ng/mL

•3 IU might raise it by 45 ng/mL (diminishing returns kick in)

•4+ IU often shows minimal additional benefit and increased side effect risk

Your dose should fall into the "sweet spot" where you're raising IGF-1 meaningfully without overshooting into problematic territory.

What High vs Low IGF-1 Means Long-Term

Consistently elevated IGF-1 (in the 75-90th percentile for your age) correlates with:

•Improved muscle recovery and protein synthesis

•Enhanced bone density (especially over 1-2 years)

•Better skin elasticity and collagen remodeling

•Potential metabolic benefits if combined with training

Consistently low IGF-1 (below 50th percentile) suggests:

•Suboptimal GH signaling

•Slower recovery from training

•Continued age-related muscle loss

•Limited dermis and collagen remodeling benefits

Retesting and Adjustment Timeline

1. Start protocol: Baseline IGF-1 test before beginning

2. Week 4-6: Retest (expecting minimal change, establishing early response)

3. Week 8-10: Retest (expect meaningful elevation if dose is adequate)

4. Weeks 12+: Test every 8-12 weeks to monitor stability and guide dose adjustments

5. If changing dose: Retest 4 weeks after adjustment

Frequent testing (weekly or monthly) is unnecessary and expensive. Your IGF-1 changes slowly; monthly testing will show noise, not signal.

Using MyProtocolStack for IGF-1 Tracking

MyProtocolStack lets you upload IGF-1 results alongside your dose logs. The platform visualizes your IGF-1 trend over months and correlates it directly to your injection timeline. You'll see exactly which dose produced which result, eliminating guesswork for future adjustments.

Common Misconceptions

"Higher IGF-1 is always better" — False. Excess GH/IGF-1 increases joint pain, carpal tunnel risk, and potentially metabolic dysfunction. The goal is optimal, not maximal.

"IGF-1 responds immediately to dose changes" — False. Changes take 2-4 weeks to become apparent. Adjusting your dose weekly based on "how you feel" is ineffective.

"IGF-1 is the only marker I need" — False. Monitor prolactin, glucose, lipids, and thyroid function alongside IGF-1 for a complete picture.

This article is for informational and educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, adjusting, or stopping any peptide protocol. MyProtocolStack is a protocol tracking and blood work analysis platform — it is not a medical device and does not provide clinical recommendations.

Track Your Labs. Build Your Protocol.

Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.

Start Free →

Not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol. Read full disclaimer →